ICFI vs. AMEH, MEG, RMR, HCKT, FCN, EXPO, DNB, CBZ, HURN, and VSEC
Should you be buying ICF International stock or one of its competitors? The main competitors of ICF International include Apollo Medical (AMEH), Montrose Environmental Group (MEG), The RMR Group (RMR), The Hackett Group (HCKT), FTI Consulting (FCN), Exponent (EXPO), Dun & Bradstreet (DNB), CBIZ (CBZ), Huron Consulting Group (HURN), and VSE (VSEC).
ICF International (NASDAQ:ICFI) and Apollo Medical (NASDAQ:AMEH) are both mid-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, media sentiment, valuation, profitability, dividends, community ranking and institutional ownership.
ICF International presently has a consensus price target of $159.50, indicating a potential upside of 10.69%. Apollo Medical has a consensus price target of $47.20, indicating a potential upside of 15.63%. Given Apollo Medical's stronger consensus rating and higher probable upside, analysts plainly believe Apollo Medical is more favorable than ICF International.
ICF International has a beta of 0.6, indicating that its stock price is 40% less volatile than the S&P 500. Comparatively, Apollo Medical has a beta of 1.04, indicating that its stock price is 4% more volatile than the S&P 500.
ICF International has a net margin of 4.74% compared to Apollo Medical's net margin of 3.56%. ICF International's return on equity of 14.42% beat Apollo Medical's return on equity.
In the previous week, ICF International had 7 more articles in the media than Apollo Medical. MarketBeat recorded 8 mentions for ICF International and 1 mentions for Apollo Medical. Apollo Medical's average media sentiment score of 0.88 beat ICF International's score of 0.34 indicating that Apollo Medical is being referred to more favorably in the news media.
ICF International has higher revenue and earnings than Apollo Medical. ICF International is trading at a lower price-to-earnings ratio than Apollo Medical, indicating that it is currently the more affordable of the two stocks.
94.1% of ICF International shares are held by institutional investors. Comparatively, 35.9% of Apollo Medical shares are held by institutional investors. 1.4% of ICF International shares are held by insiders. Comparatively, 8.5% of Apollo Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
ICF International received 209 more outperform votes than Apollo Medical when rated by MarketBeat users. Likewise, 67.38% of users gave ICF International an outperform vote while only 60.79% of users gave Apollo Medical an outperform vote.
Summary
ICF International beats Apollo Medical on 10 of the 18 factors compared between the two stocks.
Get ICF International News Delivered to You Automatically
Sign up to receive the latest news and ratings for ICFI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ICFI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ICF International Competitors List
Related Companies and Tools
